Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-13

Clinical Trial Update: Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating switching HIV patients from lopinavir/ritonavir or fosamprenavir/ritonavir to atazanavir/ritonavir or darunavir/ritonavir has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fosamprenavir/ritonavir (fosamprenavir/ritonavir)
  • Kaletra (lopinavir)
  • PREZISTA (darunavir)
  • REYATAZ (atazanavir)

Snippet

Sponsor: Community Research Initiative of New England | Conditions: HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2012-07-13